Rapid, Automatic Measurement of Glycan Structures

16 Jun 2011

Product news

Shimadzu announces the launch of Accurate Glycan Analyzer (AGA) software for the automatic measurement of glycan structures using trace-level samples. AGA takes advantage of the unique MSn capability of the AXIMA Resonance MALDI quadrupole ion trap TOF mass spectrometer.

Glycans play an important role in medical research; in the diagnosis of cancer and other diseases, and in the development of monoclonal antibodies. Sometimes called “the third chain of life” (after nucleic acids and proteins), glycans are molecules formed by a chain of "sugars" such as glucose.

Approximately 60 % of proteins in organisms exist in the form of bonded glycans. Unlike nucleic acid and proteins, which are largely linear straight chains, glycans are branched, which means that they show extreme diversity of type and structure. While this allows them to perform an important role, for example, in the identification of living things and immunization, it also makes them extremely difficult to analyse. For example, two glycans can have the same molecular weight but different structures. For this reason, despite their importance, the study of glycans has been limited to a few specialists. Now, the combination of a specialist glycan database and the unique AXIMA Resonance is making the study of glycosylation widely accessible for the first time.

The AGA software uses initial MS data to suggest precursor ions then pattern matches the resulting MS/MS spectra against the database of real (not generated theoretically) glycan spectra. If necessary, this process is repeated to MS3 and MS4 until the structure of the glycan is determined.

Due to the sensitivity of the AXIMA Resonance, structural analysis of a glycan can be achieved with nanogram-levels of sample. In addition to being completely automatic, the method is also rapid: full structural identification being achieved in just 7 minutes. This is significantly faster than previous methods.

Links

Tags

Mass SpectrometryMass spectrometry (MS) is a powerful analytical technique used to identify and quantify molecules based on the mass-to-charge ratio of gas-phase ions. It provides detailed information about the structure, composition, and properties of compounds and is widely used across fields such as environmental monitoring, materials science, drug discovery and development, food and beverage testing, and wider chemical research. Key MS techniques include tandem mass spectrometry (MS/MS), liquid chromatography–mass spectrometry (LS-MS) and inductively coupled plasma (ICP-MS). Choosing from these wide range of techniques and technologies can be a daunting task, so keep up to date with scientific applications, performance expectations, and customer reviews here all in one place. Visit our product directory to receive quotes direct from the manufacturer. GlycobiologyGlycobiology encompasses research into the biological functions, synthesis and structures of glycans, including glycoproteins, glycolipids, proteoglycans and free oligosaccharides. Mass spectrometers and their software are commonly used in the study of glycobiology, along with structure predicting tools, chromatography and NMR.MALDI-TOF MSMALDI-TOF mass spectrometers (matrix-assisted laser desorption/ionization time-of-flight) are used for the mass analysis of large molecules, including proteins, DNA, polymers and other macromolecules due to its relatively soft ionization, reducing fragmentation whilst allowing fast data acquisition. Tandem mass analyzers such as TOF/TOF systems can be used to increase resolution and sensitivity of your analysis. Find the best MALDI-TOF products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.
Rapid, Automatic Measurement of Glycan Structures